Oral Cancer

When you come to us for diagnosis or treatment for oral cancer, our multidisciplinary team of specialists works quickly to create a customized treatment plan that meets your needs. Our surgeons, periodontists, oncologists, and speech and swallowing therapists collaborate to provide comprehensive, compassionate care throughout treatment and recovery. Also, you may be eligible to participate in clinical trials, which offer new treatment approaches to oral cancer and oral precancerous growths.

Clinical Trials and Research Studies

Phase N/A

The AIM-HN and SEQ-HN Study: A 2 Cohort Non-comparative Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Learn More

Phase 3

MK-3475 (SCH 9000475) as neoadjuvant and adjuvant therapy in Stage III-IVA resectable

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More